BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9949403)

  • 1. Clinical brachytherapy with neutron emitting 252Cf sources and adherence to AAPM TG-43 dosimetry protocol.
    Rivard MJ; Wierzbicki JG; Van den Heuvel F; Martin RC; McMahon RR
    Med Phys; 1999 Jan; 26(1):87-96. PubMed ID: 9949403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry for 252Cf neutron emitting brachytherapy sources: protocol, measurements, and calculations.
    Rivard MJ
    Med Phys; 1999 Aug; 26(8):1503-14. PubMed ID: 10501050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutron dosimetry for a general 252Cf brachytherapy source.
    Rivard MJ
    Med Phys; 2000 Dec; 27(12):2803-15. PubMed ID: 11190964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurements and calculations of thermal neutron fluence rate and neutron energy spectra resulting from moderation of 252Cf fast neutrons: applications for neutron capture therapy.
    Rivard MJ
    Med Phys; 2000 Aug; 27(8):1761-9. PubMed ID: 10984222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetry of 252Cf sources for neutron radiotherapy with and without augmentation by boron neutron capture therapy.
    Yanch JC; Zamenhof RG
    Radiat Res; 1992 Sep; 131(3):249-56. PubMed ID: 1438684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of high-activity 252Cf sources for neutron brachytherapy.
    Martin RC; Laxson RR; Miller JH; Wierzbicki JG; Rivard MJ; Marsh DL
    Appl Radiat Isot; 1997; 48(10-12):1567-70. PubMed ID: 9463877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental determination of the thermal neutron flux around two different types of high intensity 252Cf sources.
    Schmidt B; Maughan RL; Yudelev M; Kota C; Wanwilairat S
    Med Phys; 1999 Jan; 26(1):83-6. PubMed ID: 9949402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo simulation of 252CF dose distribution brachytherapy.
    Böhm R; Nikodemová D; Fülöp M; Pinak M
    Med Phys; 1996 May; 23(5):707-12. PubMed ID: 8724744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound dual radiation action theory for 252Cf brachytherapy.
    Wang CK; Zhang X
    Radiat Prot Dosimetry; 2004; 110(1-4):801-6. PubMed ID: 15353749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A radiobiological model for the relative biological effectiveness of high-dose-rate 252Cf brachytherapy.
    Rivard MJ; Melhus CS; Zinkin HD; Stapleford LJ; Evans KE; Wazer DE; Odlozilíková A
    Radiat Res; 2005 Sep; 164(3):319-23. PubMed ID: 16137205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of brachytherapy with californium-252 neutrons versus cesium-137 photons for eradication of bulky localized cervical cancer: single-institution study.
    Maruyama Y; van Nagell JR; Yoneda J; Donaldson E; Gallion H; Higgins R; Powell D; Turner C; Kryscio R
    J Natl Cancer Inst; 1988 Jun; 80(7):501-6. PubMed ID: 3367388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose calculation for photon-emitting brachytherapy sources with average energy higher than 50 keV: report of the AAPM and ESTRO.
    Perez-Calatayud J; Ballester F; Das RK; Dewerd LA; Ibbott GS; Meigooni AS; Ouhib Z; Rivard MJ; Sloboda RS; Williamson JF
    Med Phys; 2012 May; 39(5):2904-29. PubMed ID: 22559663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interstitial neutron therapy using flexible 252Cf sources].
    Vtiurin BM; Medvedev VS; Ivanov VN; Elisiutin GP; Petrovskaia GA
    Med Radiol (Mosk); 1984 Jun; 29(6):7-16. PubMed ID: 6738328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measured microdosimetric spectra and therapeutic potential of boron neutron capture enhancement of 252Cf brachytherapy.
    Burmeister J; Kota C; Maughan RL
    Radiat Res; 2005 Sep; 164(3):312-8. PubMed ID: 16137204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderated 252Cf neutron energy spectra in brain tissue and calculated boron neutron capture dose.
    Rivard MJ; Zamenhof RG
    Appl Radiat Isot; 2004 Nov; 61(5):753-7. PubMed ID: 15308139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contact neutron therapy of tumors with 252Cf irradiation].
    Vtiurin BM
    Med Radiol (Mosk); 1987 Sep; 32(9):62-7. PubMed ID: 3657457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cervical cancer clearance after 252Cf neutron brachytherapy versus conventional photon brachytherapy.
    Maruyama Y; Muir W
    Am J Clin Oncol; 1984 Aug; 7(4):347-52. PubMed ID: 6741864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the expected costs of high dose rate brachytherapy using 252Cf versus 192Ir.
    Rivard MJ; Kirk BL; Stapleford LJ; Wazer DE
    Appl Radiat Isot; 2004 Dec; 61(6):1211-6. PubMed ID: 15388112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.